Tübingen researchers: A form of niacin boosts energy in nerve cells and helps prevent them from dying off. This could lead to new treatments.
Unsteady hands, stiff muscles and slow movements—all these are typical symptoms of Parkinson’s disease. Some 220,000 people in Germany are affected by the disease, which becomes more likely to occur as people get older. It is caused by the loss of nerve cells in the brain and remains incurable.
A team of researchers headed by Dr. Dr. Michela Deleidi at the Hertie Institute for Clinical Brain Research and the University of Tübingen is now reporting that nicotinamide riboside—a form of vitamin B3—may offer a possible treatment.
Initial results from the laboratory are promising: “This substance stimulates the faulty energy metabolism in the affected nerve cells and protects them from dying off,” Deleidi explains. The researchers have published their study in the latest edition of the journal Cell Reports.
Damaged power plants lead to cell death
It is still not clear precisely what leads to the development of Parkinson’s disease. Scientists do know that increasing levels of dopamine in nerve cells in the substantia nigra region of the brain die off. Recently it has been recognized that the mitochondria in these cells are damaged.
Mitochondria are responsible for producing energy, making them the mini-power plants of the cell. When they go wrong, the cell may die. “In our study we aimed to investigate whether damaged mitochondria were merely a side effect or whether they cause Parkinson's disease,” says Deleidi.
To find out, the researchers, working with international colleagues, took skin cell samples from patients with Parkinson’s disease. The stimulated the cells to turn them into stem cells, which then developed into nerve cells. The cells had a defect of what’s known as the GBA gene—the most frequent risk gene for Parkinson’s. Just like the ‘real’ nerve cells, their mitochondria—and consequently their energy production—were impaired.
Overhaul of cell power plants
The researchers then sought to stimulate the formation of new mitochondria. The coenzyme NAD plays and important role. The researchers ‘fed’ the cells with nicotinamide riboside, a form of vitamins B3 and a preliminary stage of the coenzyme. This led to a rise in the concentration of NAD in the cells. The result: “The nerve cells’ energy budget improved considerably. New mitochondria formed and energy production rose.”
In order to observe the effect of the vitamin in a living organism, the researchers took the further step of investigating flies with a GBA gene defect. As with Parkinson’s patients, the flies’ dopamine-rich nerve cells died off, and as they age, the flies have increasing difficulties in walking and climbing.
Deleidi and her colleagues divided the flies into two groups. One group received feed enriched with the vitamin, the other did not. “The substance had a positive effect here as well. In the flies which were treated, far fewer nerve cells died off.” Furthermore, they retained their mobility longer.
“Our results suggest that the loss of mitochondria does indeed play a significant role in the genesis of Parkinson’s disease,” Deleidi summarizes. “Administering nicotinamide riboside may be a new starting-point for treatment.” Further studies are needed to determine whether the vitamin can be of real help with Parkinson’s. The researchers are planning to test the effects of nicotinamide riboside on patients. Other studies have shown that it is well tolerated by healthy test subjects and boosts their energy metabolism as well,” Deleidi says.
Schöndorf DC et al. (2018): “The NAD+ precursor, nicotinamide riboside, rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease“, Cell Reports, 23(10)
Dr. Mareike Kardinal | idw - Informationsdienst Wissenschaft
New study finds distinct microbes living next to corals
22.05.2019 | Woods Hole Oceanographic Institution
Summit charts a course to uncover the origins of genetic diseases
22.05.2019 | DOE/Oak Ridge National Laboratory
Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...
With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.
Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...
'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.
However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...
Working group led by physicist Professor Ulrich Nowak at the University of Konstanz, in collaboration with a team of physicists from Johannes Gutenberg University Mainz, demonstrates how skyrmions can be used for the computer concepts of the future
When it comes to performing a calculation destined to arrive at an exact result, humans are hopelessly inferior to the computer. In other areas, humans are...
Scientists develop a molecular recording tool that enables in vivo lineage tracing of embryonic cells
The beginning of new life starts with a fascinating process: A single cell gives rise to progenitor cells that eventually differentiate into the three germ...
29.04.2019 | Event News
17.04.2019 | Event News
15.04.2019 | Event News
22.05.2019 | Life Sciences
22.05.2019 | Life Sciences
22.05.2019 | Physics and Astronomy